Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Montreal
- Most recent report
- 8-K, filed Oct 28, 2026
- Incorporated
- N/A
- Filings on record
- 421 filings
- On EDGAR
- CIK 1408443
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 33
News 8 of 74
Prospectuses and Registrations 8 of 28
- S-3 Shelf registration statement May 13, 2026
- S-8 Registration statement for an employee plan Aug 12, 2025
- 424B5 Prospectus supplement for an offering Jul 14, 2025
- 424B5 Prospectus supplement for an offering Jul 11, 2025
- 424B5 Prospectus supplement for an offering Mar 18, 2025
- S-8 Registration statement for an employee plan Mar 13, 2025
- S-3 Shelf registration statement Nov 12, 2024
- S-8 Registration statement for an employee plan Nov 12, 2024
Proxies 8 of 16
- DEFA14A Extra proxy material Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- DEFA14A Extra proxy material Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- DEFA14A Extra proxy material Jul 15, 2024
- DEFA14A Extra proxy material Jul 15, 2024
- DEF 14A Proxy statement for a shareholder vote Jul 15, 2024
- DEFA14A Extra proxy material Apr 28, 2023
Ownership 8 of 221
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
Other 8 of 49
- EFFECT Notice that a registration became effective May 22, 2026
- CORRESP Reply to SEC staff May 20, 2026
- UPLOAD Comment letter from SEC staff May 18, 2026
- ARS Annual report sent to shareholders Apr 30, 2026
- ARS Annual report sent to shareholders Apr 30, 2025
- EFFECT Notice that a registration became effective Nov 22, 2024
- CORRESP Reply to SEC staff Nov 20, 2024
- UPLOAD Comment letter from SEC staff Nov 19, 2024
Everything here comes from Milestone Pharmaceuticals Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.